Prognostic factors for renal cell carcinoma
Summary Renal cell carcinoma is a relatively uncommon tumour with a widely varying prognosis depending on several tumour and clinical factors. This review discusses these factors and critically appraises their value both as individual markers and when they are incorporated into scoring systems/model...
Gespeichert in:
| Veröffentlicht in: | Cancer treatment reviews 2008-08, Vol.34 (5), p.407-426 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 426 |
|---|---|
| container_issue | 5 |
| container_start_page | 407 |
| container_title | Cancer treatment reviews |
| container_volume | 34 |
| creator | Furniss, D Harnden, P Ali, N Royston, P Eisen, T Oliver, R.T Hancock, B.W |
| description | Summary Renal cell carcinoma is a relatively uncommon tumour with a widely varying prognosis depending on several tumour and clinical factors. This review discusses these factors and critically appraises their value both as individual markers and when they are incorporated into scoring systems/models or algorithms. Disease stage (assessed pathologically and/or clinically) and performance status have the strongest evidence as helpful individual prognostic markers but a better discrimination is obtained by combining these and adding in various other indices. Prospective validation of such integrated prognostic models will be essential. |
| doi_str_mv | 10.1016/j.ctrv.2007.12.008 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69314897</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0305737208000248</els_id><sourcerecordid>69314897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-24fd98349c6b3da34e44de5c3f814c4216d98f9767f27f4fd3c2db33f1fb533e3</originalsourceid><addsrcrecordid>eNp9kUtLxDAUhYMozjj6B1zIrNxIa15tWhBBBl8woKCuQ5reSGqnGZN2YP69KTMguHCTu8g5h3u_g9A5wSnBJL9uUt37TUoxFimhKcbFAZqSjNGElLk4RFPMcJYIJugEnYTQYIxLlpfHaEIKzrHA2RRdvXr32bnQWz03SvfOh7lxfu6hU-1cQxsf5bXt3EqdoiOj2gBn-zlDHw_374unZPny-Ly4Wyaai6xPKDd1WTBe6rxitWIcOK8h08wUhGtOSR6_TSlyYagwUcw0rSvGDDFVxhiwGbrc5a69-x4g9HJlw7iK6sANQeYlI7woRRTSnVB7F4IHI9ferpTfSoLliEg2ckQkR0SSUBkRRdPFPn2oVlD_WvZMouBmJ4B448aCl0Fb6DTU1oPuZe3s__m3f-y6tZ3Vqv2CLYTGDT6iDZLIEA3ybSxp7AgXsR_KC_YD3sqLvw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69314897</pqid></control><display><type>article</type><title>Prognostic factors for renal cell carcinoma</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Furniss, D ; Harnden, P ; Ali, N ; Royston, P ; Eisen, T ; Oliver, R.T ; Hancock, B.W</creator><creatorcontrib>Furniss, D ; Harnden, P ; Ali, N ; Royston, P ; Eisen, T ; Oliver, R.T ; Hancock, B.W ; On behalf of the National Cancer Research Institute Renal Clinical Studies Group ; National Cancer Research Institute Renal Clinical Studies Group</creatorcontrib><description>Summary Renal cell carcinoma is a relatively uncommon tumour with a widely varying prognosis depending on several tumour and clinical factors. This review discusses these factors and critically appraises their value both as individual markers and when they are incorporated into scoring systems/models or algorithms. Disease stage (assessed pathologically and/or clinically) and performance status have the strongest evidence as helpful individual prognostic markers but a better discrimination is obtained by combining these and adding in various other indices. Prospective validation of such integrated prognostic models will be essential.</description><identifier>ISSN: 0305-7372</identifier><identifier>EISSN: 1532-1967</identifier><identifier>DOI: 10.1016/j.ctrv.2007.12.008</identifier><identifier>PMID: 18440705</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Biomarkers, Tumor - metabolism ; Carcinoma, Renal Cell - epidemiology ; Carcinoma, Renal Cell - metabolism ; Carcinoma, Renal Cell - pathology ; Disease Progression ; Hematology, Oncology and Palliative Medicine ; Humans ; Kidney Neoplasms - epidemiology ; Kidney Neoplasms - metabolism ; Kidney Neoplasms - pathology ; Neoplasm Staging ; Prognosis ; Prognostic markers ; Prognostic models ; Renal cell carcinoma</subject><ispartof>Cancer treatment reviews, 2008-08, Vol.34 (5), p.407-426</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-24fd98349c6b3da34e44de5c3f814c4216d98f9767f27f4fd3c2db33f1fb533e3</citedby><cites>FETCH-LOGICAL-c475t-24fd98349c6b3da34e44de5c3f814c4216d98f9767f27f4fd3c2db33f1fb533e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ctrv.2007.12.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18440705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Furniss, D</creatorcontrib><creatorcontrib>Harnden, P</creatorcontrib><creatorcontrib>Ali, N</creatorcontrib><creatorcontrib>Royston, P</creatorcontrib><creatorcontrib>Eisen, T</creatorcontrib><creatorcontrib>Oliver, R.T</creatorcontrib><creatorcontrib>Hancock, B.W</creatorcontrib><creatorcontrib>On behalf of the National Cancer Research Institute Renal Clinical Studies Group</creatorcontrib><creatorcontrib>National Cancer Research Institute Renal Clinical Studies Group</creatorcontrib><title>Prognostic factors for renal cell carcinoma</title><title>Cancer treatment reviews</title><addtitle>Cancer Treat Rev</addtitle><description>Summary Renal cell carcinoma is a relatively uncommon tumour with a widely varying prognosis depending on several tumour and clinical factors. This review discusses these factors and critically appraises their value both as individual markers and when they are incorporated into scoring systems/models or algorithms. Disease stage (assessed pathologically and/or clinically) and performance status have the strongest evidence as helpful individual prognostic markers but a better discrimination is obtained by combining these and adding in various other indices. Prospective validation of such integrated prognostic models will be essential.</description><subject>Biomarkers, Tumor - metabolism</subject><subject>Carcinoma, Renal Cell - epidemiology</subject><subject>Carcinoma, Renal Cell - metabolism</subject><subject>Carcinoma, Renal Cell - pathology</subject><subject>Disease Progression</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Kidney Neoplasms - epidemiology</subject><subject>Kidney Neoplasms - metabolism</subject><subject>Kidney Neoplasms - pathology</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Prognostic markers</subject><subject>Prognostic models</subject><subject>Renal cell carcinoma</subject><issn>0305-7372</issn><issn>1532-1967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtLxDAUhYMozjj6B1zIrNxIa15tWhBBBl8woKCuQ5reSGqnGZN2YP69KTMguHCTu8g5h3u_g9A5wSnBJL9uUt37TUoxFimhKcbFAZqSjNGElLk4RFPMcJYIJugEnYTQYIxLlpfHaEIKzrHA2RRdvXr32bnQWz03SvfOh7lxfu6hU-1cQxsf5bXt3EqdoiOj2gBn-zlDHw_374unZPny-Ly4Wyaai6xPKDd1WTBe6rxitWIcOK8h08wUhGtOSR6_TSlyYagwUcw0rSvGDDFVxhiwGbrc5a69-x4g9HJlw7iK6sANQeYlI7woRRTSnVB7F4IHI9ferpTfSoLliEg2ckQkR0SSUBkRRdPFPn2oVlD_WvZMouBmJ4B448aCl0Fb6DTU1oPuZe3s__m3f-y6tZ3Vqv2CLYTGDT6iDZLIEA3ybSxp7AgXsR_KC_YD3sqLvw</recordid><startdate>20080801</startdate><enddate>20080801</enddate><creator>Furniss, D</creator><creator>Harnden, P</creator><creator>Ali, N</creator><creator>Royston, P</creator><creator>Eisen, T</creator><creator>Oliver, R.T</creator><creator>Hancock, B.W</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080801</creationdate><title>Prognostic factors for renal cell carcinoma</title><author>Furniss, D ; Harnden, P ; Ali, N ; Royston, P ; Eisen, T ; Oliver, R.T ; Hancock, B.W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-24fd98349c6b3da34e44de5c3f814c4216d98f9767f27f4fd3c2db33f1fb533e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biomarkers, Tumor - metabolism</topic><topic>Carcinoma, Renal Cell - epidemiology</topic><topic>Carcinoma, Renal Cell - metabolism</topic><topic>Carcinoma, Renal Cell - pathology</topic><topic>Disease Progression</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Kidney Neoplasms - epidemiology</topic><topic>Kidney Neoplasms - metabolism</topic><topic>Kidney Neoplasms - pathology</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Prognostic markers</topic><topic>Prognostic models</topic><topic>Renal cell carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Furniss, D</creatorcontrib><creatorcontrib>Harnden, P</creatorcontrib><creatorcontrib>Ali, N</creatorcontrib><creatorcontrib>Royston, P</creatorcontrib><creatorcontrib>Eisen, T</creatorcontrib><creatorcontrib>Oliver, R.T</creatorcontrib><creatorcontrib>Hancock, B.W</creatorcontrib><creatorcontrib>On behalf of the National Cancer Research Institute Renal Clinical Studies Group</creatorcontrib><creatorcontrib>National Cancer Research Institute Renal Clinical Studies Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer treatment reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Furniss, D</au><au>Harnden, P</au><au>Ali, N</au><au>Royston, P</au><au>Eisen, T</au><au>Oliver, R.T</au><au>Hancock, B.W</au><aucorp>On behalf of the National Cancer Research Institute Renal Clinical Studies Group</aucorp><aucorp>National Cancer Research Institute Renal Clinical Studies Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic factors for renal cell carcinoma</atitle><jtitle>Cancer treatment reviews</jtitle><addtitle>Cancer Treat Rev</addtitle><date>2008-08-01</date><risdate>2008</risdate><volume>34</volume><issue>5</issue><spage>407</spage><epage>426</epage><pages>407-426</pages><issn>0305-7372</issn><eissn>1532-1967</eissn><abstract>Summary Renal cell carcinoma is a relatively uncommon tumour with a widely varying prognosis depending on several tumour and clinical factors. This review discusses these factors and critically appraises their value both as individual markers and when they are incorporated into scoring systems/models or algorithms. Disease stage (assessed pathologically and/or clinically) and performance status have the strongest evidence as helpful individual prognostic markers but a better discrimination is obtained by combining these and adding in various other indices. Prospective validation of such integrated prognostic models will be essential.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>18440705</pmid><doi>10.1016/j.ctrv.2007.12.008</doi><tpages>20</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0305-7372 |
| ispartof | Cancer treatment reviews, 2008-08, Vol.34 (5), p.407-426 |
| issn | 0305-7372 1532-1967 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69314897 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Biomarkers, Tumor - metabolism Carcinoma, Renal Cell - epidemiology Carcinoma, Renal Cell - metabolism Carcinoma, Renal Cell - pathology Disease Progression Hematology, Oncology and Palliative Medicine Humans Kidney Neoplasms - epidemiology Kidney Neoplasms - metabolism Kidney Neoplasms - pathology Neoplasm Staging Prognosis Prognostic markers Prognostic models Renal cell carcinoma |
| title | Prognostic factors for renal cell carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T04%3A32%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20factors%20for%20renal%20cell%20carcinoma&rft.jtitle=Cancer%20treatment%20reviews&rft.au=Furniss,%20D&rft.aucorp=On%20behalf%20of%20the%20National%20Cancer%20Research%20Institute%20Renal%20Clinical%20Studies%20Group&rft.date=2008-08-01&rft.volume=34&rft.issue=5&rft.spage=407&rft.epage=426&rft.pages=407-426&rft.issn=0305-7372&rft.eissn=1532-1967&rft_id=info:doi/10.1016/j.ctrv.2007.12.008&rft_dat=%3Cproquest_cross%3E69314897%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69314897&rft_id=info:pmid/18440705&rft_els_id=1_s2_0_S0305737208000248&rfr_iscdi=true |